Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders (OPAL)

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: May 15, 2006
Last updated: March 24, 2009
Last verified: March 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):